BioLineRx Ltd. (BLRX) Q2 2026 Earnings Call Transcript

SA Transcripts 162.06K Followers Follow BioLineRx Ltd. ( BLRX ) Q2 2026 Earnings Call August 31, 2026 8:30 AM EDT Company Participants Philip Serlin - Chief Executive Officer Mali Zeevi - Chief Financial Officer Ella Sorani - Chief Development Officer Conference Call Participants Charles Padala John Vandermosten - Zacks Investment Research, Inc. Presentation Operator Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] I would now like to turn the call over to Chuck Padala, Investor Relations. Please go ahead. Charles Padala Thank you, operator, and welcome, everyone, and thank you for joining us on our quarterly results conference call. Earlier today, we issued a press release, a copy of which is available in the Investor Relations section of our website. It was also filed as a 6-K. I'd like to remind everyone that certain statements we make during the call will be forward-looking. Because such statements deal with future events and are subject to many risks and uncertainties, actual results may differ materially from those in the forward-looking statements. For a full discussion of these risks and uncertainties, please review our annual report on Form 20-F and our quarterly reports on Form 6-K that are filed with the U.S. Securities and Exchange Commission. At this time, it is now my pleasure to turn the call over to Mr. Phil Serlin, Chief Executive Officer of BioLineRx. Philip Serlin Chief Executive Officer Thank you, Chuck, and good morning, everyone, and thank you for joining us on today's call. As has been our practice, I will begin with a few prepared remarks before turning the call over to Mali Zeevi, our Chief Financial Officer, to briefly recap our financials. Afterwards, we will take your questions. Ella Sorani, our Chief Development Officer, is also available for Q&A. I'd